Impact of 18F-FES PET on the Therapeutic Treatment of Patients With Metastatic Breast Cancer
Clinical trial NCT05486182 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05486182
- Sponsor
- GE Healthcare
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-08
- Primary completion
- 2025-04-18
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.